Sarepta Therapeutics(SRPT) has had a wild ride this week, losing nearly 20% after an FDA vote on Tuesday that denied accelerated approval to its Duchenne muscular dystrophy drug, eteplirsen.
Yet the stock closed up 13.5% to $13.80 Thursday. Today, TheStreet.com argued that hope isnt lost for a speedy FDA approval, despite the negative vote earlier this week, and that sentiment was echoed by Jim Cramer, who talked up drugs safety profile.
The thesis is that Dr. Janet Woodcock, who will have the final say on the drug, is more favorably disposed than the rest of the panel. Woodcock, the director of the FDAs Center for Drug Evaluation and Research, met with families of patients suffering from the muscle-wasting disease, and some have interpreted her remarks to mean shes still open to approval.
Of course, Barrons readers already knew this, after Andrew Bary argued Tuesday that eteplirsens slim hopes rest with Woodcock.
Sarepta shares were down to $3.94 when that article was published, so investors who bought then would have netted a 250% gain by the end of trading today.
best shares to invest in now: Alder BioPharmaceuticals, Inc.(ALDR)
Advisors’ Opinion:
- [By Paul Ausick]
Alder Biopharmaceuticals Inc. (NASDAQ: ALDR) posted a new 52-week low of $13.50on Tuesday, down nearly 28% compared with Monday’s closing price of $18.70. The stock’s 52-week high is $36.48. Volume totaled more than 12 million shares, about 12 times the daily average of around 720,000. The company reported that its migraine treatment reported a positive result, but investors were not impressed.
best shares to invest in now: Jewett-Cameron Trading Company(JCTCF)
Advisors’ Opinion:
- [By Lisa Levin]
Jewett-Cameron Trading Company Ltd (NASDAQ: JCTCF) shares shot up 11 percent to $13.35. Jewett-Cameron reported Q3 earnings of $0.53 per share on revenue of $16.7 million.
best shares to invest in now: BioLineRx Ltd.(BLRX)
Advisors’ Opinion:
- [By Jim Robertson]
On Friday, our Under the Radar Moversnewsletter suggested small cap clinical-stage biopharmaceutical stockBioline RX Ltd (NASDAQ: BLRX) as a speculative buy:
best shares to invest in now: Alphabet Inc.(GOOGL)
Advisors’ Opinion:
- [By Ezra Schwarzbaum]
Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) announced last week that Google chrome will automatically block all advertisements on sites that feature a certain level unacceptable ad formats identified by the Coalition for Better Ads, reported the Wall Street Journal.
- [By Jack Delaney]
Alphabet (GOOGL) doesn’t seem like your typical growth stock, considering it opened at $1,030.99 this morning (Oct. 27, 2017). But Wall Street is overlooking the explosive potential our tech guru sees…
- [By WWW.THESTREET.COM]
As stocks rallied following last week’s election, Apple (APPL) , Amazon (AMZN) , Alphabet (GOOGL) and Facebook (FB) bucked the positive stock market momentum and now have negative weekly chart profiles.
- [By Jack Delaney]
Just a month earlier, Waymo, the self-driving car company of Alphabet Inc. (Nasdaq: GOOGL), announced in May it was partnering with Lyft to develop new autonomous vehicle technologies.
- [By Leo Sun]
Even Alphabet’s (NASDAQ:GOOG) (NASDAQ:GOOGL) YouTube, the biggest streaming video platform in theworld with over a billion users, remains unprofitable due to those pressures. Last October, YouTube CEO Susan Wojcicki stated that the 12-year-old site was “still in investment mode,” and that there was “no timetable” for achieving profitability. Like iQiyi, YouTube offers a premium subscription platform, YouTube Red, but theservice reportedly only had 1.5 million subscribers at the end of last summer.
best shares to invest in now: First Harvest Corp., Prior to Reverse Merger with Cannavoices, Inc. (HVST)
Advisors’ Opinion:
- [By Javier Hasse]
First Harvest Corp (OTC: HVST), acquired Cannavoices, Inc., a developer of cannabis-focused mobile games and social media platforms.
"A trend we've seen developing slowly but steadily [is one] wherenew channels are being developed to reach cannabis consumers, primarily due to limits in advertising. There is so much regulation in the space that, in such an entrepreneurial environment where there are really no incumbent leaders, people are trying to be creative and figuring out ways to reach the cannabis consumer, both as an undeserved demographic and, just one that has still got that taboo around it, [leading] to larger players not necessarily getting involved yet." "Basically, they are trying to figure out ways to reach the consumer without direct TV advertising and stuff like that.”
Related Link: Marijuana Stocks Go On Reversal Mode After 8 Weeks Of Gains: Cannabis Index Down From 52-Week High
best shares to invest in now: Royal Bank Scotland plc (The)(RBS)
Advisors’ Opinion:
- [By Paul R. La Monica]
European banks worse off than 2008? Lamensdorf is concerned about the exposure to bad loans (especially energy company debt) held by big banks such as Royal Bank of Scotland (RBS), Credit Suisse (CS) and Deutsche Bank (DB). He’s shorting all three.
- [By Jonathan Morgan]
Adidas AG slid 2.9 percent after lowering its profit forecast for 2013. Direct Line Insurance Group Plc lost 2.5 percent as Royal Bank of Scotland Group Plc (RBS) sold a 630 million-pound ($1 billion) stake in the U.K.s biggest car insurer.
